SF3B1 and cancer: Large-scale cancer genome sequencing projects have identified recurrent somatic mutations in SF3B1 in several types of hematological malignancies including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and myelodysplastic syndromes (MDS) (4–6).